Literature DB >> 12584527

When do the federal regulations allow placebo-controlled trials in children?

Franklin G Miller1, David Wendler, Benjamin Wilfond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584527     DOI: 10.1067/mpd.2003.43

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Assent in paediatric research: theoretical and practical considerations.

Authors:  D S Wendler
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

2.  Quality improvement ethics: lessons from the SUPPORT study.

Authors:  Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

Review 3.  Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings.

Authors:  Kanesha Simmons; Robin Ortiz; Joe Kossowsky; Peter Krummenacher; Christian Grillon; Daniel Pine; Luana Colloca
Journal:  Pain       Date:  2014-08-29       Impact factor: 6.961

4.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

5.  Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.

Authors:  Michael W Konstan; Drucy Borowitz; Nicole Mayer-Hamblett; Carlos Milla; Leslie Hendeles; Susan Murray; Richard A Kronmal; Susan Casey; Lynn M Rose; Wayne J Morgan; Bonnie W Ramsey
Journal:  Clin Investig (Lond)       Date:  2013-08

Review 6.  Neuropathic pain in children: Special considerations.

Authors:  Gary A Walco; Robert H Dworkin; Elliot J Krane; Alyssa A LeBel; Rolf-Detlef Treede
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

7.  Incidental findings in pediatric research.

Authors:  Benjamin S Wilfond; Katherine J Carpenter
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.